This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Company Profile: Safeguard Scientifics provides growth capital for entrepreneurial and innovative life sciences and technology companies.
Share Price: $13.28 (Sept. 26)
Performance Since July 25: -27.5%
Gundlach's View: Gundlach views Safeguard Scientifics not as a bank but as a cross between a venture-capital firm and a private-equity shop. What attracted Gundlach, though, was the increasing rate of revenue growth.
Revenue growth of their partner companies is up substantially," he says. "In 2007, their partner companies had $100 million in aggregate revenue, which grew to $400 million in 2010."
Safeguard Scientifics currently has minority stakes of 20% to 40% in 13 companies, such as pharmaceutical company
NuPathe, Internet career site
Beyond.com and digital media trading technology provider
MediaMath. Safeguard represents a solid investment for Gundlach and his team because these 13 business have been performing very well.
"Right now, the stock price of Safeguard is barely trading higher than the net cash on their balance sheet," Gundlach points out. "Effectively, you're getting their ownership stakes in 13 different companies for free, a variety of which are pretty exciting investment opportunities."
>>To see these stocks in action, visit the
3 Beaten-Down Small-Cap Growth Stocks portfolio on Stockpickr.
-- Written by Robert Holmes in Boston.
>To contact the writer of this article, click here:
>To follow Robert Holmes on Twitter, go to
>To submit a news tip, send an email to: